Back

Predictors of irreversible pulmonary hypertension reduction with Sildenafil therapy in heart transplant candidates

29 April 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Pulmonary hypertension Pulmonary hypertension HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Doctor Agata Duszanska

American Heart of Poland, Kedzierzyn-Kozle (Poland)

8 More presentations in this session

Presentation thumbnail
Exercise pulmonary artery pressure change as a prognostic parameter in heart failure
Professor I. Sari (Gaziantep, TR)
Presentation thumbnail
Early diagnosis of severe right ventricular dysfunction in pulmonary arterial hypertension through clinical evaluation. Insights from Argentine RECOPILAR Registry
Doctor E. Perna (Corrientes, AR)
Abstract Slides
Presentation thumbnail
Gender differences in functional capacity, quality of life, anxiety, depression and common symptoms in pulmonary arterial hypertension patients
Professor S. Kucukoglu (Istanbul, TR)
Abstract
Presentation thumbnail
Morbidity and mortality in patients with pulmonary hypertension treated with iloprost
Presentation thumbnail
Right ventricular 18F-FDG uptake in PET/MRI hybrid and hemodynamics in patients with pulmonary arterial hypertension.
Professor K. Kaminski (Bialystok, PL)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Pulmonary hypertension

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources